Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams

Veterinary Therapeutics

Volumn 7, Issue 3, 2006, Pages 295-304

  Ellsworth, Michael A ^a   Fairbanks, Kris K ^a   Behan, Stephen ^a   Jackson, James A ^a   Goodyear, Mark ^a   Oien, Nancee L ^a   Meinert, Todd R ^a   Leyh, Randy D ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE DIARRHEA VIRUS; BREEDING; CATTLE; CATTLE DISEASE; DISEASE TRANSMISSION; FEMALE; FETUS DISEASE; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATION; SERODIAGNOSIS; VACCINATION; VIROLOGY;

ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUS 2, BOVINE VIRAL; FEMALE; FETAL DISEASES; NEUTRALIZATION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY, ANIMAL; VACCINATION; VACCINES, COMBINED; VIRAL VACCINES;

BOVINE VIRAL DIARRHEA VIRUS TYPE 2;

EID: 33845698102     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Houe H: Economic impact of BVDV infection in dairies. Biologicals 31:137-143, 2003.
2. Grooms DL: Reproductive consequences of infection with bovine viral diarrhea virus. Vet Clin North Am Food Anim Pract 20:5-19, 2004.
3. Campbell JR: Effect of bovine viral diarrhea virus in feedlot. Vet Clin North Am Food Animal Practice 20:39-50, 2004.
4. Cortese VS, Grooms DL, Ellis J, et al: Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine. Am J Vet Res 59(11):1409-1413, 1998.
5. Ellsworth MA, Kelling CL, Dickinson EO, et al: Fetal infection following intravenous bovine viral diarrhea virus challenge of vaccinated and unvaccinated dams [abstract]. Proc Conf Res Work Anim Dis:34, 1994.
6. Brownlie J, Clarke MC, Hooper LB, et al: Protection of the bovine fetus from bovine viral diarrhea virus by means of a new inactivated vaccine. Vet Rec 137:58-62, 1995.
7. Brock KV, Cortese VS: Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine. Vet Ther 2:354-360, 2001.
8. Patel JR, Shileto RW, Williams J, et al: Prevention of transplacental infection of bovine foetus by bovine viral diarrhea virus through vaccination. Arch Virol 47:2453-2463, 2002.
9. Zimmer GM, Wentink GH, Bruschke C, et al: Failure of foetal protection after vaccination against an experimental infection with bovine viral diarrhea virus. Vet Microbiol 89:255-265, 2002.
10. Dean HJ, Hunsaker BD, Bailey OD, et al: Prevention of persistent infection in calves by vaccination of dams with noncytopathic type-1 modified-live bovine viral diarrhea virus prior to breeding. Am J Vet Res 64:530-537, 2003.
11. Fairbanks KK, Rinehart CK, Ohnesorge WC, et al: Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination with a bivalent modified-live virus vaccine. JAVMA 225:1898-1904, 2004.
12. Bolin SR, McClurkin AW, Coria MF: Frequency of persistent bovine viral diarrhea virus infection in selected cattle herds. Am J Vet Res 46(11):2385-2387, 1985.
13. Howard CJ, Brownlie J, Thomas LH: Prevalence of bovine virus diarrhea virus viraemia in cattle in the UK. Vet Rec 119(25):628-629, 1986.
14. Witturn TE, Grotelueschen DM, Brock KV, et al: Persistent bovine viral diarrhoea virus infection in US beef herds. Prev Vet Med 49:83-94, 1996.
15. Baker JC: Bovine viral diarrhea: A review. JAVMA 190:1449-1458, 1987.
16. Munoz-Zanzi CA, Hietala SK, Thurmond MC, et al: Quantification, risk factors, and health impact of natural congenital infection with bovine viral diarrhea virus in dairy calves. Am J Vet Res 64:358-365, 2003.
17. Compendium of Veterinary Products, ed 9. Port Huron, MI, North American Compendiums, 2006.
18. Ridpath JF, Bolin SR: Differentiation of types 1a, 1b and 2 bovine diarrhea virus (BVDV) by PCR. Mol Cell Probes 12:101-106, 1998.
19. Thompson JD, Gibson TJ, Plewniak F, et al: The Clustal X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25(24):4876-4882, 1997.
20. Schmidt NJ, Emmons RW (ed): Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. Baltimore, American Public Health Association, 1989, pp 20-21.
21. Haines DM, Clark EG, Dubovi EJ: Monoclonal antibody-based immunohistochemical detection of bovine viral diarrhea virus in formalin-fixed, paraffin-embedded tissues. Vet Pathol 29(1):27-32, 1992.
22. SAS/STAT Software: Changes and Enhancements through Release 6.12. SAS Institute, Cary, NC.
23. Fulton RW, Briggs RE, Ridpath JF, et al. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves. Can J Vet Res 69:161-169, 2005.
24. Dean HJ, Leyh R: Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge. Vaccine 17:1117-1124, 1999.
25. Fairbanks K, Schnackel J, Chase CCL: Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge. Vet Ther 4(1):24-34, 2003.
26. nd Symposium on Pestiviruses. Lyon, France, 1993, pp 117-121.
27. Baker JC: The clinical manifestation of bovine viral diarrhea infection. Vet Clin North Am Food Anim Pract 11:425-446, 1995.